Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indication
Berlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended aflibercept 8 mg (114.3 mg/ml solution for injection) for…
